Numerate Inc., a San Bruno, Calif.-based drug engineering company, has raised around $5.5 million in Series B funding, according to a regulatory filing. Backers include Foundation Capital and Lanza TechVentures.
100 Deals associated with Lanza TechVentures
Login to view more data
100 Translational Medicine associated with Lanza TechVentures
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.